90%

of RNA users interviewed

Require faster and more access to RNA

#1 issue

Scalability of RNA from small to large

Scalability is often ranked No.1 among manufacturers

>US$50b 

RNA/mRNA market size

Combined use of RNA for: Gene editing, vaccines, agriculture, Neoantigen cancer Vaccines, etc

~2 Months

For mRNA to be synthesised and tested

Including assembling template, RNA production, purification and QC